Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadja Zaborsky

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Oncotarget|September 7, 2019
Mouse models to decipher anti-tumor immunityThomas Parigger, Richard Greil, Nadja Zaborsky
International Journal of Molecular Sciences|August 27, 2021
CAR T-Cell Therapy in Hematological MalignanciesTheresa Haslauer, Richard Greil, Nadja Zaborsky, et al.
Cancers|February 24, 2019
Next Generation Sequencing in AML-On the Way to Becoming a New Standard for Treatment Initiation and/or Modulation?Michael Leisch, Bettina Jansko, Nadja Zaborsky, et al.
Pharmaceuticals (Basel, Switzerland)|February 3, 2021
miRNA-Based Therapeutics in the Era of Immune-Checkpoint InhibitorsFlorian Huemer, Michael Leisch, Roland Geisberger, et al.
International Journal of Molecular Sciences|February 15, 2022
Detecting Bacterial-Human Lateral Gene Transfer in Chronic Lymphocytic LeukemiaEkaterina Akimova, Franz Josef Gassner, Richard Greil, et al.
Cancers|May 9, 2020
RNA Editing Alters miRNA Function in Chronic Lymphocytic LeukemiaFranz J Gassner, Nadja Zaborsky, Daniel Feldbacher, et al.
Plos One|September 9, 2010
HPK1 associates with SKAP-HOM to negatively regulate Rap1-mediated B-lymphocyte adhesionSebastian Königsberger, Doris Peckl-Schmid, Nadja Zaborsky, et al.
Plos One|February 25, 2012
Lysine residue at position 22 of the AID protein regulates its class switch activityRoland Geisberger, Michael Huemer, Franz J Gassner, et al.
International Journal of Molecular Sciences|April 25, 2020
Combination Strategies for Immune-Checkpoint Blockade and Response Prediction by Artificial IntelligenceFlorian Huemer, Michael Leisch, Roland Geisberger, et al.
Arbeiten Aus Dem Paul-Ehrlich-Institut (Bundesinstitut Fur Impfstoffe Und Biomedizinische Arzneimittel) Langen/Hessen|June 11, 2014
Physicochemical characterization of recombinant allergens and hypoallergenic variantsMartin Himly, Michael Wallner, Nadja Zaborsky, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Oncotarget|September 7, 2019
Mouse models to decipher anti-tumor immunityThomas Parigger, Richard Greil, Nadja Zaborsky
International Journal of Molecular Sciences|August 27, 2021
CAR T-Cell Therapy in Hematological MalignanciesTheresa Haslauer, Richard Greil, Nadja Zaborsky, et al.
Cancers|February 24, 2019
Next Generation Sequencing in AML-On the Way to Becoming a New Standard for Treatment Initiation and/or Modulation?Michael Leisch, Bettina Jansko, Nadja Zaborsky, et al.
Pharmaceuticals (Basel, Switzerland)|February 3, 2021
miRNA-Based Therapeutics in the Era of Immune-Checkpoint InhibitorsFlorian Huemer, Michael Leisch, Roland Geisberger, et al.
International Journal of Molecular Sciences|February 15, 2022
Detecting Bacterial-Human Lateral Gene Transfer in Chronic Lymphocytic LeukemiaEkaterina Akimova, Franz Josef Gassner, Richard Greil, et al.
Cancers|May 9, 2020
RNA Editing Alters miRNA Function in Chronic Lymphocytic LeukemiaFranz J Gassner, Nadja Zaborsky, Daniel Feldbacher, et al.
Plos One|September 9, 2010
HPK1 associates with SKAP-HOM to negatively regulate Rap1-mediated B-lymphocyte adhesionSebastian Königsberger, Doris Peckl-Schmid, Nadja Zaborsky, et al.
Plos One|February 25, 2012
Lysine residue at position 22 of the AID protein regulates its class switch activityRoland Geisberger, Michael Huemer, Franz J Gassner, et al.
International Journal of Molecular Sciences|April 25, 2020
Combination Strategies for Immune-Checkpoint Blockade and Response Prediction by Artificial IntelligenceFlorian Huemer, Michael Leisch, Roland Geisberger, et al.
Arbeiten Aus Dem Paul-Ehrlich-Institut (Bundesinstitut Fur Impfstoffe Und Biomedizinische Arzneimittel) Langen/Hessen|June 11, 2014
Physicochemical characterization of recombinant allergens and hypoallergenic variantsMartin Himly, Michael Wallner, Nadja Zaborsky, et al.
Pageof 6